{"key":"op_800_TR","page":{"url":"https://fr.bookimed.com/clinics/country=turkey/procedure=car-t-cell-therapy/","procedure":{"id":800,"slug":"car-t-cell-therapy","name":"Thérapie CAR T","name_forms":{"plural":{"status":"missing","reason":"not_collected"},"genitive":{"status":"missing","reason":"not_collected"}},"type":"therapy","grammar_number":{"status":"missing","reason":"not_collected"},"parent_id":"hematology","family_attribute":{"status":"missing","reason":"not_collected"}},"country":{"id":46,"iso":"TR","name":"Turquie"},"currency":"USD","data_date":"2026-09-25"},"pages":{"clinics_url":"https://fr.bookimed.com/clinics/country=turkey/procedure=car-t-cell-therapy/","cost_url":"https://fr.bookimed.com/clinics/country=turkey/procedure=car-t-cell-therapy/cost/","best_url":{"status":"missing","reason":"template not live"}},"price":{"from":150000,"to":220000,"avg":{"value":200000,"method":"median","source":"offers"},"us":{"from":420000,"to":540000},"uk":{"from":330000,"to":420000},"by_technique":{"status":"missing","reason":"not_collected"},"by_city":[{"city":"Istanbul","from":150000},{"city":"Ankara","from":155000},{"city":"Antalya","from":140000},{"city":"Izmir","from":150000}],"per_unit":{"status":"missing","reason":"not_collected"},"factors":{"status":"missing","reason":"not_collected"},"tiers":{"source":"offers","items":[{"tier":"premium","min":200000,"max":200000,"median":200000,"count":1}]},"comparison":[{"country_iso":"UA","from":90000,"to":150000},{"country_iso":"FR","from":295000,"to":385000},{"country_iso":"GB","from":330000,"to":420000},{"country_iso":"US","from":420000,"to":540000},{"country_iso":"IL","from":84000,"to":405000},{"country_iso":"MX","from":120000,"to":185000},{"country_iso":"DE","from":285000,"to":365000},{"country_iso":"CA","from":340000,"to":470000},{"country_iso":"AE","from":190000,"to":310000},{"country_iso":"TH","from":150000,"to":220000},{"country_iso":"PL","from":165000,"to":230000},{"country_iso":"KR","from":220000,"to":300000},{"country_iso":"CZ","from":150000,"to":195000},{"country_iso":"AT","from":280000,"to":365000},{"country_iso":"ES","from":380000,"to":520000},{"country_iso":"IT","from":400000,"to":650000},{"country_iso":"CN","from":275000,"to":319000},{"country_iso":"AU","from":330000,"to":420000},{"country_iso":"IN","from":38000,"to":70000},{"country_iso":"MY","from":120000,"to":180000},{"country_iso":"VN","from":150000,"to":230000},{"country_iso":"BR","from":280000,"to":400000}],"base_country":"US","base_is_fallback":false},"savings":{"pct":64,"variant":">=15%"},"package":{"included":["24-hr nurse services","Blood tests","Consultation with a hematologist","Biopsy","Chest X-ray","Consultation of a radiologist","Consultation with a cardiologist","Consultation with an oncologist","ECG mapping (Cardiac mapping)","Full board (breakfast+lunch+dinner+drinks)","Hospitalization","PET/CT","Transfer airport-hotel-clinic-airport","VIP transfer (premium vehicle service, all transfers between airport, hotel and clinic)"],"excluded":["Accommodation is not included"],"extra_charges":{"status":"missing","reason":"not_collected"}},"clinics":{"count":6,"items":[{"id":2943,"name":"Istanbul Florence Nightingale Hospital","city":"Istanbul","rating":5,"reviews_count":58,"accreditations":["Joint Commission International","International Organization for Standardization"],"rank":1,"has_procedure":true,"why_ranked":"Offers CAR T-cell therapy with a 28-day hospitalization protocol. Prof. Sevindik specializes in hematologic malignancies and has published on refractory cases. JCI-accredited facility with dedicated hematology department.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":[{"id":"68f8b8d472bb9e02c5086eb5","price":200000,"nights":28,"included":["Consultation with a hematologist","Blood tests","24-hr nurse services","VIP transfer (premium vehicle service, all transfers between airport, hotel and clinic)"],"excluded":["Accommodation is not included"],"other_services":"Please find below a breakdown of the CAR-T cell therapy - Collecting: Your T cells (a kind of white blood cell) will be taken from your blood. - Reprogramming: A special receptor called a CAR (Chimeric Antigen Receptor) will be added to these T cells in a special laboratory — This helps the T cells to recognize and attack cancer cells. - Multiply: The modified T cells are grown into millions of copies. - Infuse: These “super-charged” T cells will be put back into your body through an IV. - Attack: The CAR-T cells will start to find and destroy the cancer cells."}]},{"id":426,"name":"Hisar Hospital Intercontinental","city":"Istanbul","rating":4.5,"reviews_count":266,"accreditations":["Joint Commission International","Turkish Medical Association (Türk Tabıplerı Bırliği)","Turkish Medical Association","Patient choice in Oncology & Hematology Oncology","Best patient assistance","Best clinic for radiotherapy"],"rank":2,"has_procedure":true,"why_ranked":"JCI-accredited hematology department with specialized CAR T-cell therapy. Doctor has performed 900+ treatments and prepares personalized plans. Includes remission monitoring with PET-CT and bone marrow analysis.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":85,"name":"Medipol Mega University Hospital","city":"Istanbul","rating":4.5,"reviews_count":495,"accreditations":["Joint Commission International","Patient choice in Pediatric Oncology & Hematology Oncology"],"rank":3,"has_procedure":true,"why_ranked":"Specializes in hard-to-treat cases with CAR T-cell therapy and autologous transplants. JCI accredited with a dedicated adult and pediatric bone marrow transplantation center.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":1173,"name":"Emsey Hospital","city":"Istanbul","rating":4.1,"reviews_count":42,"accreditations":["The Baby-friendly Hospital Initiative (BFHI) by WHO and UNICEF","Turkish Medical Association","TEMOS International Healthcare Accreditation","Certification according to DIN EN ISO 9001 by TÜV NORD CERT","International Health Tourism Authorization Certificate","International Organization for Standardization"],"rank":4,"has_procedure":true,"why_ranked":"Largest pediatric and adult Bone Marrow Transplantation Unit in the region with 45 beds. Specializes in high-risk cases and offers HEPA-filtered rooms for safety.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":3887,"name":"Private Koru Ankara Hospital","city":"Ankara","rating":2,"reviews_count":1,"accreditations":["Turkish Medical Association","Joint Commission International"],"rank":5,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":1602,"name":"Acibadem Altunizade Clinic","city":"Istanbul","rating":4.4,"reviews_count":7,"accreditations":["International Organization for Standardization","Joint Commission International","LEED Platinum Sertificate for ECO Buildings"],"rank":6,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}}]},"doctors":{"count":13,"languages":{"status":"missing","reason":"not_collected"}},"cities":[{"id":107,"slug":"istanbul","name":"Istanbul","clinics_count":3,"price_from":150000,"profile":{"city_type":"Largest city in Turkey, megacity","access":["Sabiha Gökçen Airport (SAW), 32 km southeast of city center"],"sources":["https://en.wikipedia.org/wiki/Istanbul","https://en.wikipedia.org/wiki/Sabiha_G%C3%B6k%C3%A7en_International_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":386,"slug":"ankara","name":"Ankara","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":155000,"profile":{"city_type":"Capital city of Turkey","access":["Ankara Airport (ESB), 28 km from the city center"],"sources":["https://en.wikipedia.org/wiki/Ankara","https://en.wikipedia.org/wiki/Ankara_Esenboğa_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":382,"slug":"antalya","name":"Antalya","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":140000,"profile":{"city_type":"Major Mediterranean coastal city in Turkey","access":["Antalya Airport (AYT), 13 km from the city center"],"sources":["https://en.wikipedia.org/wiki/Antalya","https://en.wikipedia.org/wiki/Antalya_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":395,"slug":"izmir","name":"Izmir","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":150000,"profile":{"city_type":"Aegean coastal port city in Turkey","access":["Izmir Airport (ADB), 14 km from the city center"],"sources":["https://en.wikipedia.org/wiki/%C4%B0zmir","https://en.wikipedia.org/wiki/Izmir_Adnan_Menderes_Airport"],"checked_at":"2026-11-03","status":"ok"}}],"offers":{"active":2,"active_with_related":2,"hospital_nights_median":28,"days_in_country_median":{"status":"missing","reason":"fewer than 10 offers with hotel days"},"top_offers":[{"id":"68f8b8d472bb9e02c5086eb5","clinic_id":2943,"clinic_listed":true,"price":200000,"nights":28,"transfer":{"status":"missing","reason":"not_collected"},"tests":{"status":"missing","reason":"not_collected"},"meds":{"status":"missing","reason":"not_collected"},"aftercare":{"status":"missing","reason":"not_collected"},"guarantee":{"status":"missing","reason":"not_collected"},"included":["Consultation with a hematologist","Blood tests","24-hr nurse services","VIP transfer (premium vehicle service, all transfers between airport, hotel and clinic)"],"excluded":["Accommodation is not included"],"other_services":"Please find below a breakdown of the CAR-T cell therapy - Collecting: Your T cells (a kind of white blood cell) will be taken from your blood. - Reprogramming: A special receptor called a CAR (Chimeric Antigen Receptor) will be added to these T cells in a special laboratory — This helps the T cells to recognize and attack cancer cells. - Multiply: The modified T cells are grown into millions of copies. - Infuse: These “super-charged” T cells will be put back into your body through an IV. - Attack: The CAR-T cells will start to find and destroy the cancer cells.","is_package":true},{"id":"68f8d02f9b859e8a9803799c","clinic_id":5611,"clinic_listed":false,"price":300000,"nights":28,"transfer":{"status":"missing","reason":"not_collected"},"tests":{"status":"missing","reason":"not_collected"},"meds":{"status":"missing","reason":"not_collected"},"aftercare":{"status":"missing","reason":"not_collected"},"guarantee":{"status":"missing","reason":"not_collected"},"included":["Full board (breakfast+lunch+dinner+drinks)","Biopsy","Consultation of a radiologist","Consultation with a cardiologist","Consultation with a hematologist","Consultation with an oncologist","PET/CT","ECG mapping (Cardiac mapping)","Chest X-ray","Blood tests","24-hr nurse services","Hospitalization","Transfer airport-hotel-clinic-airport"],"excluded":{"status":"missing","reason":"not_collected"},"other_services":"World-Class Expertise: Led by Prof. Dr. Tunç Fışgın, one of Türkiye’s leading hematologists and cellular therapy experts. Accredited Cellular Laboratory: Collaboration with Acıbadem Labcell GMP-Certified Laboratory, ensuring the highest safety and production quality for CAR-T cells. Comprehensive & Seamless Care: Full-cycle management from diagnosis, cell collection, genetic engineering, infusion, and follow-up — all coordinated by one hospital. Advanced Oncology Center: Bahçelievler Hospital hosts Turkey’s leading hematology, oncology, and bone marrow transplant units, supported by multidisciplinary teams. Tailored Patient Management: Each case is personalized — treatment intensity, dose, and follow-up are adjusted according to disease progression and patient profile. International Patient Support: Dedicated multilingual coordinators for full assistance (visa, accommodation, airport transfers, translation, post-treatment support). Safety and Comfort: Modern inpatient rooms, infection-controlled environment, and continuous monitoring for 24/7 patient safety. Bridging Chemotherapy Option: Patients who require continued management before CAR-T infusion can stay under direct medical supervision without needing re-hospitalization later.","is_package":true}],"packages":[{"id":"68f8b8d472bb9e02c5086eb5","clinic_id":2943,"clinic_listed":true,"price":200000,"nights":28,"transfer":{"status":"missing","reason":"not_collected"},"tests":{"status":"missing","reason":"not_collected"},"meds":{"status":"missing","reason":"not_collected"},"aftercare":{"status":"missing","reason":"not_collected"},"guarantee":{"status":"missing","reason":"not_collected"},"included":["Consultation with a hematologist","Blood tests","24-hr nurse services","VIP transfer (premium vehicle service, all transfers between airport, hotel and clinic)"],"excluded":["Accommodation is not included"],"other_services":"Please find below a breakdown of the CAR-T cell therapy - Collecting: Your T cells (a kind of white blood cell) will be taken from your blood. - Reprogramming: A special receptor called a CAR (Chimeric Antigen Receptor) will be added to these T cells in a special laboratory — This helps the T cells to recognize and attack cancer cells. - Multiply: The modified T cells are grown into millions of copies. - Infuse: These “super-charged” T cells will be put back into your body through an IV. - Attack: The CAR-T cells will start to find and destroy the cancer cells.","is_package":true},{"id":"68f8d02f9b859e8a9803799c","clinic_id":5611,"clinic_listed":false,"price":300000,"nights":28,"transfer":{"status":"missing","reason":"not_collected"},"tests":{"status":"missing","reason":"not_collected"},"meds":{"status":"missing","reason":"not_collected"},"aftercare":{"status":"missing","reason":"not_collected"},"guarantee":{"status":"missing","reason":"not_collected"},"included":["Full board (breakfast+lunch+dinner+drinks)","Biopsy","Consultation of a radiologist","Consultation with a cardiologist","Consultation with a hematologist","Consultation with an oncologist","PET/CT","ECG mapping (Cardiac mapping)","Chest X-ray","Blood tests","24-hr nurse services","Hospitalization","Transfer airport-hotel-clinic-airport"],"excluded":{"status":"missing","reason":"not_collected"},"other_services":"World-Class Expertise: Led by Prof. Dr. Tunç Fışgın, one of Türkiye’s leading hematologists and cellular therapy experts. Accredited Cellular Laboratory: Collaboration with Acıbadem Labcell GMP-Certified Laboratory, ensuring the highest safety and production quality for CAR-T cells. Comprehensive & Seamless Care: Full-cycle management from diagnosis, cell collection, genetic engineering, infusion, and follow-up — all coordinated by one hospital. Advanced Oncology Center: Bahçelievler Hospital hosts Turkey’s leading hematology, oncology, and bone marrow transplant units, supported by multidisciplinary teams. Tailored Patient Management: Each case is personalized — treatment intensity, dose, and follow-up are adjusted according to disease progression and patient profile. International Patient Support: Dedicated multilingual coordinators for full assistance (visa, accommodation, airport transfers, translation, post-treatment support). Safety and Comfort: Modern inpatient rooms, infection-controlled environment, and continuous monitoring for 24/7 patient safety. Bridging Chemotherapy Option: Patients who require continued management before CAR-T infusion can stay under direct medical supervision without needing re-hospitalization later.","is_package":true}],"related_packages":{"status":"missing","reason":"not_collected"},"other_packages":{"status":"missing","reason":"not_classified"}},"medical":{"indications":["Relapsed or refractory large B-cell lymphoma","Relapsed or refractory B-cell acute lymphoblastic leukemia","Relapsed or refractory follicular and mantle cell lymphoma","Relapsed or refractory multiple myeloma (BCMA-directed)","Relapsed or refractory chronic lymphocytic leukemia"],"contraindications":["Active uncontrolled infection, including uncontrolled hepatitis B/C or HIV","Significant cardiac, pulmonary, renal or hepatic dysfunction","Active CNS or autoimmune neurological disease (relative, product-dependent)","Poor performance status or rapid progression during manufacturing (relative)","Severe hypersensitivity to DMSO or product excipients","Pregnancy or breastfeeding","Active uncontrolled graft-versus-host disease (relative, prior transplant)"],"operation_hours":{"min":0.5,"max":1,"unit":"hours","qualifier":"Duration of the single CAR T-cell infusion itself; leukapheresis (about 3-6 hours) and lymphodepletion are separate."},"anesthesia":["none"],"sessions_or_stages":{"sessions":{"min":1,"max":1,"unit":"visits","qualifier":"One CAR T-cell infusion; leukapheresis and lymphodepletion are preceding stages."},"stages":[{"code":"leukapheresis","label":"Leukapheresis to collect T cells","after":{"min":0,"max":0,"unit":"days","qualifier":"Starting point of the treatment pathway"}},{"code":"lymphodepletion","label":"Lymphodepleting chemotherapy","after":{"min":23,"max":58,"unit":"days","qualifier":"About 3-8 weeks after leukapheresis; 2-5 days before infusion"}},{"code":"car_t_infusion","label":"CAR T-cell infusion","after":{"min":28,"max":63,"unit":"days","qualifier":"Depends on manufacturing and product release time"}}],"qualifier":"Single-infusion therapy; timelines vary by product and center."},"hospital_nights":{"value":28,"source":"offers","parsed_details":{"min":10,"max":21,"unit":"nights","qualifier":"Inpatient stay with daily CRS/ICANS monitoring, about 2 weeks; longer if ICU needed."}},"treatment_conditions":["inpatient"],"rehabilitation_days":{"min":60,"max":90,"unit":"days","qualifier":"Functional recovery after the 4-week monitoring period; slower with persistent fatigue, cytopenias, neurotoxicity or infections."},"fly_home_after_days":{"min":28,"max":42,"unit":"days","qualifier":"Stay near the centre at least 4 weeks, past peak CRS/ICANS risk. Fly if no toxicity, counts acceptable."},"back_to_work_days":{"min":60,"max":90,"unit":"days","qualifier":"Desk work usually resumes at 2–3 months, once CRS/ICANS risk and cytopenias settle. Later if fatigue, neurotoxicity or infections persist."},"exercise_resume_weeks":{"min":8,"max":12,"unit":"weeks","qualifier":"Strenuous exercise waits about 2–3 months, until counts recover and early neurotoxicity and infection risk passes. Light walking earlier."},"final_result_months":{"min":1,"max":3,"unit":"months","qualifier":"Response is assessed at about 1 month and 3 months after infusion; remission durability needs longer follow-up."},"result_longevity":"In large B-cell lymphoma, about 40% remain progression-free at 1 year; some stay in long-term remission. In B-ALL, about 36% relapse; CAR T cells can persist up to about 5 years.","main_risks":["Cytokine release syndrome","Immune effector cell-associated neurotoxicity syndrome","Prolonged cytopenias","Infections and hypogammaglobulinemia","B-cell aplasia","Hemophagocytic lymphohistiocytic-like syndrome","Secondary T-cell malignancies (rare)","Tumor lysis syndrome","Infusion-related hypersensitivity reactions"],"complication_rate_pct":{"min":50,"max":95,"unit":"percent","qualifier":"Any-grade cytokine release syndrome or neurotoxicity within about 8 weeks; severe grade 3+ events roughly 10-25%."},"revision_rate_pct":{"status":"missing","reason":"not_collected"},"success":{"metric":"Complete response rate in relapsed/refractory large B-cell lymphoma (3rd-line or later)","value":51,"horizon":"Best response, typically assessed at 1-3 months after infusion","source":{"status":"missing","reason":"not_collected"},"evidence_status":"limited"},"scars":"There is no surgical incision, only small puncture marks from the leukapheresis or central venous line sites.","pain":"The infusion itself is generally painless; fever, headache, body aches and malaise may occur with cytokine release, and leukapheresis involves line placement with mild discomfort.","preparation":["Specialist eligibility assessment and disease staging","Infection screening and organ function evaluation","Leukapheresis to collect the patient's T cells","Possible bridging therapy while the cells are manufactured (weeks)","Lymphodepleting chemotherapy a few days before infusion","Central venous access as needed","Arrange nearby accommodation and a caregiver after infusion","Confirm target antigen (e.g., CD19, BCMA) and prior-therapy eligibility","Pre-infusion premedication (paracetamol and antihistamine)","Access to tocilizumab and ICU-level support before infusion"],"recovery_timeline":[{"phase":"Infusion and first 1-2 weeks","description":"Single IV infusion followed by close monitoring for cytokine release syndrome and neurotoxicity, usually peaking in the first 1-2 weeks.","restrictions":["Stay near the treatment center"]},{"phase":"Weeks 2-4","description":"Discharge when stable, frequent visits, blood count and infection monitoring, first response assessment around day 28.","restrictions":["Stay near the treatment center until about day 28","No driving for at least 8 weeks","Avoid crowds and infection exposure"]},{"phase":"Months 2-12","description":"Gradual recovery of blood counts and energy, immune function monitoring, immunoglobulin replacement if needed, response reassessment.","restrictions":["Delay live vaccines per specialist advice"]}],"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":7,"max":14,"unit":"days","qualifier":"Frequent early monitoring for cytokine release syndrome and neurotoxicity if discharged"}},{"purpose":"result_review","requirement":"routine","after":{"min":28,"max":35,"unit":"days","qualifier":"First response assessment, about day 28-35 after infusion"}},{"purpose":"result_review","requirement":"routine","after":{"min":85,"max":100,"unit":"days","qualifier":"Response reassessment about day 85-100 (around 3 months) after infusion"}}],"sources":{"status":"missing","reason":"not_collected"},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Ask the clinic for examples of the practitioners' experience with the exact procedure you are planning","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Ask for examples of the practitioners’ experience with the surgery you are intending to have.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C2","text":"Ask whether a doctor is always present in the clinic and whether a high dependency or intensive care unit exists","scope":"treatment_abroad","source":{"url":"https://www.bapras.org.uk/public/patient-information/cosmetic-surgery/cosmetic-surgery-abroad","host":"bapras.org.uk","quote":"Is there always a doctor in the clinic and is there a high dependency or intensive care unit?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C3","text":"Confirm the surgeon is trained and experienced in the exact procedure you are considering, not just in surgery generally","scope":"treatment_abroad","source":{"url":"https://www.isaps.org/discover/patients-home/considering-your-procedure-abroad/finding-a-surgeon-abroad/","host":"isaps.org","quote":"Verify that the surgeon is trained and experienced in performing the procedure you are considering.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C4","text":"Check that the surgeon who consults with you is the same person who will carry out the procedure","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Check that the surgeon you consult with, will be the same person carrying out the procedure.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C5","text":"Decide before you travel where check-ups after the operation will take place, because follow-up abroad may be missing or weaker","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/conditions/cosmetic-procedures/cosmetic-surgery-abroad/","host":"nhs.uk","quote":"You need to think about where check-ups will take place.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Pressure to decide quickly, or cheap time-limited offers, is a warning sign of a clinic offer","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"F2","text":"An advert or information that guarantees complete success should raise concerns","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F3","text":"Forceful persuasion or cheap, time-limited offers pushing you into a quick decision","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Confusion or difficulty communicating","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2019/cancer-immunotherapy-investigating-side-effects","host":"cancer.gov","quote":"Patients also may experience neurologic symptoms such as confusion, tremors, or difficulty communicating.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W2","text":"Excessive sleepiness","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/research/car-t-cells","host":"cancer.gov","quote":"Some of the hallmark signs of ICANS include confusion, excessive sleepiness, and impaired speech.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W3","text":"Trouble breathing","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/flu-symptoms","host":"cancer.gov","quote":"Immunotherapy treatments such as CAR T-cell therapy and some monoclonal antibodies may cause cytokine release syndrome (CRS), a condition that can lead to severe flu-like symptoms as well as a rash, rapid heartbeat, low blood pressure, and trouble breathing.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W4","text":"Fever","urgency":"contact_clinic","general":true,"source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2019/cancer-immunotherapy-investigating-side-effects","host":"cancer.gov","quote":"Many patients who receive CAR T-cell therapy develop a condition known as cytokine release syndrome, which can cause a fever, fast heart rate, low blood pressure, and rash, among other symptoms.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Shows emergency staff and other doctors the patient is a CAR T recipient","document":"car t wallet card","source":{"url":"https://www.mskcc.org/cancer-care/patient-education/car-cell-therapy-guide-adult-patients-caregivers","host":"mskcc.org","quote":"Carry your wallet card with you at all times.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T2","text":"Home doctor needs the plan the treating team set for leaving hospital","document":"written discharge instructions","source":{"url":"https://www.mskcc.org/cancer-care/patient-education/car-cell-therapy-guide-adult-patients-caregivers","host":"mskcc.org","quote":"Your CAR T team will give you discharge instructions before you leave the hospital.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T3","text":"Home doctor needs the exact medicines to continue treatment safely","document":"discharge medicines list","source":{"url":"https://www.cuh.nhs.uk/patient-information/discharge-advice-from-ward-c10c9-following-car-t-cell-therapy/","host":"cuh.nhs.uk","quote":"You will be given a copy of all the medications that you should take after being discharged.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["none"],"back_to_work_days":{"min":60,"max":90,"unit":"days","qualifier":"Desk work usually resumes at 2–3 months, once CRS/ICANS risk and cytopenias settle. Later if fatigue, neurotoxicity or infections persist."},"complication_rate_pct":{"min":50,"max":95,"unit":"percent","qualifier":"Any-grade cytokine release syndrome or neurotoxicity within about 8 weeks; severe grade 3+ events roughly 10-25%."},"contraindications":["Active uncontrolled infection, including uncontrolled hepatitis B/C or HIV","Significant cardiac, pulmonary, renal or hepatic dysfunction","Active CNS or autoimmune neurological disease (relative, product-dependent)","Poor performance status or rapid progression during manufacturing (relative)","Severe hypersensitivity to DMSO or product excipients","Pregnancy or breastfeeding","Active uncontrolled graft-versus-host disease (relative, prior transplant)"],"days_in_clinic":{"min":10,"max":21,"unit":"nights","qualifier":"Inpatient stay with daily CRS/ICANS monitoring, about 2 weeks; longer if ICU needed."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":8,"max":12,"unit":"weeks","qualifier":"Strenuous exercise waits about 2–3 months, until counts recover and early neurotoxicity and infection risk passes. Light walking earlier."},"final_result_months":{"min":1,"max":3,"unit":"months","qualifier":"Response is assessed at about 1 month and 3 months after infusion; remission durability needs longer follow-up."},"fly_home_after_days":{"min":28,"max":42,"unit":"days","qualifier":"Stay near the centre at least 4 weeks, past peak CRS/ICANS risk. Fly if no toxicity, counts acceptable."},"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":7,"max":14,"unit":"days","qualifier":"Frequent early monitoring for cytokine release syndrome and neurotoxicity if discharged"}},{"purpose":"result_review","requirement":"routine","after":{"min":28,"max":35,"unit":"days","qualifier":"First response assessment, about day 28-35 after infusion"}},{"purpose":"result_review","requirement":"routine","after":{"min":85,"max":100,"unit":"days","qualifier":"Response reassessment about day 85-100 (around 3 months) after infusion"}}],"indications":["Relapsed or refractory large B-cell lymphoma","Relapsed or refractory B-cell acute lymphoblastic leukemia","Relapsed or refractory follicular and mantle cell lymphoma","Relapsed or refractory multiple myeloma (BCMA-directed)","Relapsed or refractory chronic lymphocytic leukemia"],"main_risks":["Cytokine release syndrome","Immune effector cell-associated neurotoxicity syndrome","Prolonged cytopenias","Infections and hypogammaglobulinemia","B-cell aplasia","Hemophagocytic lymphohistiocytic-like syndrome","Secondary T-cell malignancies (rare)","Tumor lysis syndrome","Infusion-related hypersensitivity reactions"],"pain":"The infusion itself is generally painless; fever, headache, body aches and malaise may occur with cytokine release, and leukapheresis involves line placement with mild discomfort.","preparation":["Specialist eligibility assessment and disease staging","Infection screening and organ function evaluation","Leukapheresis to collect the patient's T cells","Possible bridging therapy while the cells are manufactured (weeks)","Lymphodepleting chemotherapy a few days before infusion","Central venous access as needed","Arrange nearby accommodation and a caregiver after infusion","Confirm target antigen (e.g., CD19, BCMA) and prior-therapy eligibility","Pre-infusion premedication (paracetamol and antihistamine)","Access to tocilizumab and ICU-level support before infusion"],"recovery_timeline":[{"phase":"Infusion and first 1-2 weeks","description":"Single IV infusion followed by close monitoring for cytokine release syndrome and neurotoxicity, usually peaking in the first 1-2 weeks.","restrictions":["Stay near the treatment center"]},{"phase":"Weeks 2-4","description":"Discharge when stable, frequent visits, blood count and infection monitoring, first response assessment around day 28.","restrictions":["Stay near the treatment center until about day 28","No driving for at least 8 weeks","Avoid crowds and infection exposure"]},{"phase":"Months 2-12","description":"Gradual recovery of blood counts and energy, immune function monitoring, immunoglobulin replacement if needed, response reassessment.","restrictions":["Delay live vaccines per specialist advice"]}],"rehabilitation_days":{"min":60,"max":90,"unit":"days","qualifier":"Functional recovery after the 4-week monitoring period; slower with persistent fatigue, cytopenias, neurotoxicity or infections."},"result_longevity":"In large B-cell lymphoma, about 40% remain progression-free at 1 year; some stay in long-term remission. In B-ALL, about 36% relapse; CAR T cells can persist up to about 5 years.","revision_rate_pct":null,"scars":"There is no surgical incision, only small puncture marks from the leukapheresis or central venous line sites.","sessions_or_stages":{"sessions":{"min":1,"max":1,"unit":"visits","qualifier":"One CAR T-cell infusion; leukapheresis and lymphodepletion are preceding stages."},"stages":[{"code":"leukapheresis","label":"Leukapheresis to collect T cells","after":{"min":0,"max":0,"unit":"days","qualifier":"Starting point of the treatment pathway"}},{"code":"lymphodepletion","label":"Lymphodepleting chemotherapy","after":{"min":23,"max":58,"unit":"days","qualifier":"About 3-8 weeks after leukapheresis; 2-5 days before infusion"}},{"code":"car_t_infusion","label":"CAR T-cell infusion","after":{"min":28,"max":63,"unit":"days","qualifier":"Depends on manufacturing and product release time"}}],"qualifier":"Single-infusion therapy; timelines vary by product and center."},"success":{"metric":"Complete response rate in relapsed/refractory large B-cell lymphoma (3rd-line or later)","value":51,"unit":"percent","horizon":"Best response, typically assessed at 1-3 months after infusion","evidence_status":"limited","population":"Adults with relapsed/refractory LBCL after two or more prior lines"},"techniques":[{"name":"Autologous CD19-directed CAR T-cell therapy","suits_whom":"Relapsed/refractory B-cell lymphomas and B-ALL","recovery":"Inpatient monitoring about 10-21 days, then nearby follow-up to day 28."},{"name":"Autologous BCMA-directed CAR T-cell therapy","suits_whom":"Relapsed/refractory multiple myeloma after multiple prior lines","recovery":"Similar monitoring; prolonged cytopenias are common."}],"treatment_conditions":["inpatient"],"treatment_duration_hours":{"min":0.5,"max":1,"unit":"hours","qualifier":"Duration of the single CAR T-cell infusion itself; leukapheresis (about 3-6 hours) and lymphodepletion are separate."},"initial_assessment_documents":["Pathology report with CD19 or BCMA status","Summary of prior treatment lines and responses","Recent PET-CT or MRI report","Bone marrow biopsy report","Recent CBC, kidney and liver function tests","Echocardiogram report (if available)"],"travel_trips":{"min":1,"max":2,"one_trip_possible":true,"qualifier":"Cell collection, then 3-9 weeks manufacturing, usually at home; return for infusion and 4+ weeks nearby. One trip means staying."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Ask the clinic for examples of the practitioners' experience with the exact procedure you are planning","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Ask for examples of the practitioners’ experience with the surgery you are intending to have.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C2","text":"Ask whether a doctor is always present in the clinic and whether a high dependency or intensive care unit exists","scope":"treatment_abroad","source":{"url":"https://www.bapras.org.uk/public/patient-information/cosmetic-surgery/cosmetic-surgery-abroad","host":"bapras.org.uk","quote":"Is there always a doctor in the clinic and is there a high dependency or intensive care unit?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C3","text":"Confirm the surgeon is trained and experienced in the exact procedure you are considering, not just in surgery generally","scope":"treatment_abroad","source":{"url":"https://www.isaps.org/discover/patients-home/considering-your-procedure-abroad/finding-a-surgeon-abroad/","host":"isaps.org","quote":"Verify that the surgeon is trained and experienced in performing the procedure you are considering.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C4","text":"Check that the surgeon who consults with you is the same person who will carry out the procedure","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Check that the surgeon you consult with, will be the same person carrying out the procedure.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C5","text":"Decide before you travel where check-ups after the operation will take place, because follow-up abroad may be missing or weaker","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/conditions/cosmetic-procedures/cosmetic-surgery-abroad/","host":"nhs.uk","quote":"You need to think about where check-ups will take place.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Pressure to decide quickly, or cheap time-limited offers, is a warning sign of a clinic offer","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"F2","text":"An advert or information that guarantees complete success should raise concerns","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F3","text":"Forceful persuasion or cheap, time-limited offers pushing you into a quick decision","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Confusion or difficulty communicating","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2019/cancer-immunotherapy-investigating-side-effects","host":"cancer.gov","quote":"Patients also may experience neurologic symptoms such as confusion, tremors, or difficulty communicating.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W2","text":"Excessive sleepiness","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/research/car-t-cells","host":"cancer.gov","quote":"Some of the hallmark signs of ICANS include confusion, excessive sleepiness, and impaired speech.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W3","text":"Trouble breathing","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/flu-symptoms","host":"cancer.gov","quote":"Immunotherapy treatments such as CAR T-cell therapy and some monoclonal antibodies may cause cytokine release syndrome (CRS), a condition that can lead to severe flu-like symptoms as well as a rash, rapid heartbeat, low blood pressure, and trouble breathing.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W4","text":"Fever","urgency":"contact_clinic","general":true,"source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2019/cancer-immunotherapy-investigating-side-effects","host":"cancer.gov","quote":"Many patients who receive CAR T-cell therapy develop a condition known as cytokine release syndrome, which can cause a fever, fast heart rate, low blood pressure, and rash, among other symptoms.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Shows emergency staff and other doctors the patient is a CAR T recipient","document":"car t wallet card","source":{"url":"https://www.mskcc.org/cancer-care/patient-education/car-cell-therapy-guide-adult-patients-caregivers","host":"mskcc.org","quote":"Carry your wallet card with you at all times.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T2","text":"Home doctor needs the plan the treating team set for leaving hospital","document":"written discharge instructions","source":{"url":"https://www.mskcc.org/cancer-care/patient-education/car-cell-therapy-guide-adult-patients-caregivers","host":"mskcc.org","quote":"Your CAR T team will give you discharge instructions before you leave the hospital.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T3","text":"Home doctor needs the exact medicines to continue treatment safely","document":"discharge medicines list","source":{"url":"https://www.cuh.nhs.uk/patient-information/discharge-advice-from-ward-c10c9-following-car-t-cell-therapy/","host":"cuh.nhs.uk","quote":"You will be given a copy of all the medications that you should take after being discharged.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"You are older and not eligible for CAR T-cell therapy","name":"Bispecific antibody therapy","source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2022/tecvayli-multiple-myeloma","host":"cancer.gov","quote":"with bispecific antibodies you'll be able to treat older patients who are not eligible for CAR T-cell therapies","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":null}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"technique_details":{"status":"ok","items":[{"id":"autologous-cd19-directed-car","name":"Autologous CD19-directed CAR T-cell therapy","how_it_works":{"text":"Modified T cells recognize an antigen on cancer cells","source":{"url":"https://www.leedsth.nhs.uk/?p=50458","host":"leedsth.nhs.uk","quote":"These new receptors will enable the T-cells to recognise and attach to the antigen on the cancer cell.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"autologous-bcma-directed-car","name":"Autologous BCMA-directed CAR T-cell therapy","how_it_works":{"text":"Engineered cells are designed to recognize BCMA, a protein on myeloma cells","source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2021/fda-ide-cel-car-t-multiple-myeloma","host":"cancer.gov","quote":"genetic engineering lets the CAR T cells \"see\" BCMA, a protein that's present at high amounts in multiple myeloma cells","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1}}},"techniques":[{"id":"autologous-cd19-directed-car","name":"Autologous CD19-directed CAR T-cell therapy","how_it_works":{"id":"H1","text":"Modified T cells recognize an antigen on cancer cells","source":{"url":"https://www.leedsth.nhs.uk/?p=50458","host":"leedsth.nhs.uk","quote":"These new receptors will enable the T-cells to recognise and attach to the antigen on the cancer cell.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Relapsed/refractory B-cell lymphomas and B-ALL","price_from":{"status":"missing","reason":"not_collected"},"recovery":"Inpatient monitoring about 10-21 days, then nearby follow-up to day 28."},{"id":"autologous-bcma-directed-car","name":"Autologous BCMA-directed CAR T-cell therapy","how_it_works":{"id":"H1","text":"Engineered cells are designed to recognize BCMA, a protein on myeloma cells","source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2021/fda-ide-cel-car-t-multiple-myeloma","host":"cancer.gov","quote":"genetic engineering lets the CAR T cells \"see\" BCMA, a protein that's present at high amounts in multiple myeloma cells","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Relapsed/refractory multiple myeloma after multiple prior lines","price_from":{"status":"missing","reason":"not_collected"},"recovery":"Similar monitoring; prolonged cytopenias are common."}],"alternatives":{"status":"ok","items":[{"id":"A1","text":"You are older and not eligible for CAR T-cell therapy","name":"Bispecific antibody therapy","source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2022/tecvayli-multiple-myeloma","host":"cancer.gov","quote":"with bispecific antibodies you'll be able to treat older patients who are not eligible for CAR T-cell therapies","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":null}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"diagnostic":{"status":"not_applicable"},"country":{"why":{"status":"ok","items":[{"id":"Y1","text":"Turkey's Ministry of Health publishes lists of authorized healthcare providers and facilitators holding authorization certificates","specialties":[],"source":{"url":"https://shgmturizmdb.saglik.gov.tr/EN-69410/announcements.html","host":"shgmturizmdb.saglik.gov.tr","quote":"Updated lists of healthcare providers and facilitators that have been granted authorization certificates by the Ministry","tier":"government","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-05-11","version":1},"travel":{"status":"ok","items":[{"id":"V1","item":"visa","audience":"uk","volatile":true,"text":"UK citizen passport holders can visit Turkey without a visa for up to 90 days in any 180-day period, for business or tourism","source":{"url":"https://www.gov.uk/foreign-travel-advice/turkey/entry-requirements","host":"gov.uk","quote":"You can visit Turkey without a visa for up to 90 days in any 180-day period, for business or tourism.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V2","item":"visa","audience":"us","volatile":true,"text":"US ordinary passport holders are exempt from a visa for up to 90 days in any 180-day period in Turkey","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Turkey.html","host":"travel.state.gov","quote":"Ordinary passport holders are exempted from visa up to 90 days in any 180-day period.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V3","item":"passport_validity","audience":"uk","volatile":true,"text":"A UK passport must expire at least 150 days after arrival in Turkey and have at least 1 blank page","source":{"url":"https://www.gov.uk/foreign-travel-advice/turkey/entry-requirements","host":"gov.uk","quote":"To enter Turkey, your passport must have an ‘expiry date’ at least 150 days after the date you arrive and at least 1 blank page.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V4","item":"passport_validity","audience":"us","volatile":true,"text":"A US passport must be valid for six months beyond the entry date into Turkey","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Turkey.html","host":"travel.state.gov","quote":"Passports must be valid for six months beyond your entry date.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V5","item":"prescriptions","audience":"uk","volatile":false,"text":"British prescriptions are not accepted in pharmacies in Turkey","source":{"url":"https://www.gov.uk/foreign-travel-advice/turkey/health","host":"gov.uk","quote":"British prescriptions are not accepted in pharmacies in Turkey.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V6","item":"emergency_number","audience":"all","volatile":false,"text":"Dial 112 and ask for an ambulance in Turkey","source":{"url":"https://www.gov.uk/foreign-travel-advice/turkey/health","host":"gov.uk","quote":"Dial 112 and ask for an ambulance.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2026-12-11","version":1},"other_countries_with_page":["austria","china","germany","israel","italy","lithuania","republic-of-korea","spain","united-kingdom","united-states"]},"often_combined_with":{"status":"missing","reason":"not_collected"},"reviews":{"avg_rating":4.51,"count":869,"scope":"clinic","rating_scale":5,"pros":{"status":"missing","reason":"not_collected"},"cons":{"status":"missing","reason":"not_collected"}},"current":{"seo_text":"<p>CAR T-cell therapy in Turkey costs from _op_800_price_from_ to _op_800_price_to_ on average. The total price depends on the specific cellular product used, the patient's condition, and the length of specialized monitoring. In the US, the average price is _price_compare_US_average_, while Turkey offers savings of approximately _price_percent_discount_%. Most packages include T-cell collection, genetic engineering, and a 21 to 28-day hospital stay.</p>\n\n<ul>\n<li><strong>Standard CAR-T protocols:</strong> _op_800_price_from_ to _op_800_price_to_ including apheresis and cell manufacturing.</li>\n<li><strong>Hospital monitoring:</strong> Typically covers a 28-day inpatient stay for intensive post-infusion observation.</li>\n<li><strong>Diagnostic evaluations:</strong> Covers pre-treatment bone marrow biopsies, PET/CT scans, and comprehensive blood panels.</li>\n<li><strong>Medical logistics:</strong> Often includes VIP transfers between the airport and clinic plus translation services.</li>\n</ul>\n\n<p><strong>Bookimed Expert Insight:</strong> Opting for JCI-accredited hubs like Istanbul Florence Nightingale or Medical Park Bahcelievler ensures high-tier safety. While packages start around $200,000, they often include exhaustive diagnostics like ECG mapping and PET/CT. This all-inclusive approach prevents budget creep during the critical 28-day recovery period. Families often prefer Istanbul clinics for their experience with international patients from over 160 countries.</p>","faq":[{"q":"How are side effects like CRS or neurotoxicity managed?","a":"<p>CAR T-cell therapy side effects are managed through a tiered protocol of anti-cytokine medications and corticosteroids. In Turkey, Joint Commission International-accredited centers utilize tocilizumab to reverse cytokine release syndrome and dexamethasone for neurotoxicity. Clinical teams provide 24-hour monitoring during a 28-day inpatient stay to ensure immediate intervention.</p> <ul> <li><strong>Cytokine Release Syndrome:</strong> Managed with intravenous tocilizumab (IL-6 inhibitor) to block systemic inflammatory responses.</li> <li><strong>Neurotoxicity (ICANS):</strong> Treated primarily with high-dose dexamethasone as tocilizumab cannot cross the blood-brain barrier.</li> <li><strong>Seizure prophylaxis:</strong> Neurologists prescribe levetiracetam and perform daily cognitive assessments using the standardized ICE score.</li> <li><strong>Supportive care:</strong> Includes aggressive hydration, antipyretics for fever, and supplemental oxygen within intensive care units.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While many believe CAR-T requires only a short visit, Turkey’s top hematologists at clinics like Istanbul Florence Nightingale enforce a strict 28-day hospitalization. This duration is not just for observation; it ensures immediate access to tocilizumab, which must be administered within hours of a fever to prevent higher-grade complications. With packages around $200,000—compared to _price_compare_US_average_ in the US—this extended stay is a critical safety buffer that is often financially inaccessible elsewhere.</p> <p><strong>Patient Consensus:</strong> Patients report that low-grade side effects feel like a severe flu. They emphasize that early reporting of tremors or confusion is vital, as symptoms typically resolve within 1–3 days after receiving the correct medication.</p>"},{"q":"Which hospitals in Turkey are known for CAR T-cell therapy?","a":"<p>Leading Turkish hospitals for CAR T-cell therapy include Anadolu Medical Center, Memorial Şişli, and Medical Park Bahçelievler. These JCI-accredited facilities treat complex blood cancers using advanced cellular immunotherapy. Specialized centers in Istanbul and Ankara provide required 28-day monitoring periods overseen by hematologists from the European Bone Marrow Transplant Group.</p> <ul> <li><strong>Anadolu Medical Center:</strong> Affiliated with Johns Hopkins Medicine, maintaining JACIE-accredited bone marrow transplant standards.</li> <li><strong>Istanbul Florence Nightingale:</strong> Features a Mayo Clinic-trained hematologist and Turkey's first certified smart-and-green hospital facility.</li> <li><strong>Medical Park Bahçelievler:</strong> Offers specialized pediatric CAR T-cell programs led by SIOP and EBMT-certified experts.</li> <li><strong>Memorial Şişli Hospital:</strong> The first JCI-accredited hospital in Turkey, known for high-volume cellular therapy procedures.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While many global centers offer CAR T-cell therapy, Turkish clinics like Medical Park Bahçelievler and Istanbul Florence Nightingale distinguish themselves by including 28 full days of inpatient hospitalization. This extensive stay is crucial for managing potential side effects like cytokine release syndrome and is often bundled into the procedure price, whereas US facilities frequently charge these as separate, significant daily costs.</p> <p><strong>Patient Consensus:</strong> Patients emphasize the importance of verifying whether the protocol is a local clinical trial or an internationally approved treatment. Many choose private centers like Acibadem or Anadolu to bypass the bureaucratic delays often found in public university research hospitals.</p>"},{"q":"Is CAR T-cell therapy available in Turkey?","a":"<p>CAR T-cell therapy is available in Turkey at specialized JCI-accredited hematology centers for treating relapsed B-cell malignancies. Leading facilities like Istanbul Florence Nightingale Hospital and Memorial Healthcare Group provide these advanced immunotherapies, often at _price_percent_discount_% lower costs than the United States.</p> <ul> <li><strong>Treatment focus:</strong> Primarily targets acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL).</li> <li><strong>Hospital stay:</strong> Most protocols require a 28-day stay for intensive side-effect monitoring.</li> <li><strong>Cell manufacturing:</strong> Engineering the patient's T-cells typically requires a 2-to-3 month wait.</li> <li><strong>Expert access:</strong> Surgeons like Dr. Osman Ilhan performed Turkey's first stem cell transplants.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While base procedure prices range from _op_800_price_from_ to _op_800_price_to_, the diagnostic phase is exceptionally thorough in Turkey. Clinics like Medical Park Bahcelievler include specialized cardiac mapping and PET/CT scans in their CAR-T packages. This comprehensive screening is vital because the therapy places significant stress on the cardiovascular system.</p> <p><strong>Patient Consensus:</strong> Patients emphasize the importance of verifying if the clinic uses EMA-approved products. They often recommend budgeting for an extended stay beyond the initial 4-week hospitalization.</p>"},{"q":"What is included in a typical CAR T-cell therapy package?","a":"<p>A typical CAR T-cell therapy package in Turkey includes the entire clinical sequence from initial leukapheresis to post-infusion recovery. Core components involve genetically engineering patient T-cells, lymphodepletion chemotherapy, the specialized cellular infusion, and intensive inpatient monitoring for complications like cytokine release syndrome.</p> <ul> <li><strong>Medical evaluations:</strong> Includes PET/CT scans, biopsies, ECG mapping, and consultations with multi-disciplinary hematology-oncology teams.</li> <li><strong>Clinical manufacturing:</strong> Covers T-cell collection via leukapheresis, laboratory genetic modification, and rigorous quality control testing.</li> <li><strong>Hospital stay:</strong> Packages typically bundle a 28-day inpatient stay for 24-hour nursing and acute monitoring.</li> <li><strong>Patient logistics:</strong> Most Turkish centers provide VIP airport-clinic transfers and dedicated international patient coordinators.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While US CAR T-cell therapy costs _price_compare_US_average_ on average, Turkish packages like those at Medical Park Bahcelievler Hospital offer comprehensive care for $300,000. These specific packages are distinguished by including a full 28-day hospital stay rather than the standard 7–14 days elsewhere. This longer inpatient period is a critical safety buffer, as it ensures immediate access to specialized care during the entire high-risk window for neurotoxicity.</p> <p><strong>Patient Consensus:</strong> Patients emphasize requesting a detailed breakdown of what monitoring specifically includes, as late-stage follow-up or symptom management medications may sometimes be billed separately. Successful outcomes often depend on verifying upfront what happens if cells do not meet manufacturing quality standards.</p>"},{"q":"How long is the post-infusion monitoring period?","a":"<p>Post-infusion monitoring for CAR T-cell therapy in Turkey typically requires 28 days of continuous hospitalization. This intensive observation period ensures immediate medical intervention for specific complications like cytokine release syndrome or neurological toxicities. Specialized hematology units provide around-the-clock nursing care and daily diagnostic screenings during this phase.</p> <ul> <li><strong>Hospital stay:</strong> Protocols at JCI-accredited centers include a mandatory 28 days of inpatient monitoring.</li> <li><strong>Vital tracking:</strong> Medical teams conduct 24-hour nurse monitoring of blood pressure, temperature, and oxygen.</li> <li><strong>Neurological checks:</strong> Doctors perform daily symptom logs to detect early signs of immune effector cell-associated neurotoxicity.</li> <li><strong>Diagnostic frequency:</strong> Patients undergo frequent blood tests and screenings to manage liver function and platelets.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While global guidelines suggest 14 days, top-tier Turkish centers like Istanbul Florence Nightingale Hospital bundle 28 days of hospitalization into their standard CAR T-cell packages. This extended stay provides a significant safety buffer for managing delayed reactions without incurring extra daily room costs, which can protect your budget from unexpected medical inflation.</p> <p><strong>Patient Consensus:</strong> Many patients find the 2-week mark most critical for monitoring fevers, often requiring a total stay of 18 days if mild complications arise. Experts recommend packing for isolation and verifying that the facility follows European Medicines Agency protocols for cytokine release syndrome.</p>"},{"q":"What types of cancer can be treated with CAR T-cell therapy in Turkey?","a":"<p>CAR T-cell therapy in Turkey primarily treats refractory or relapsed blood cancers, including B-cell Acute Lymphoblastic Leukemia (B-ALL), Diffuse Large B-cell Lymphoma (DLBCL), and Mantle Cell Lymphoma. Leading JCI-accredited centers in Istanbul and Ankara utilize this genetically modified T-cell infusion for advanced hematologic malignancies.</p> <ul> <li><strong>Pediatric leukemia:</strong> High success rates for B-cell Acute Lymphoblastic Leukemia in children and adults.</li> <li><strong>Aggressive lymphomas:</strong> Effective for Diffuse Large B-cell Lymphoma and advanced Follicular Lymphoma cases.</li> <li><strong>Multiple myeloma:</strong> Available for patients resistant to proteasome inhibitors and standard immunomodulatory drugs.</li> <li><strong>Clinical trials:</strong> Ongoing research targets solid tumors like brain, lung, and prostate cancers.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While many clinics offer CAR-T, the 28-day mandatory hospital stay is a critical differentiator. Centers like Medical Park Bahcelievler provide full-board hospitalization within their $300,000 packages. This long-term monitoring is essential for managing cytokine release syndrome, a common side effect of this intensive immunotherapy.</p> <p><strong>Patient Consensus:</strong> Patients emphasize that CAR-T is strictly for advanced, relapsed cases. Many survivors recommend confirming specific indications like DLBCL with clinic databases before traveling to ensure eligibility for these high-cost treatments.</p>"},{"q":"What is the success rate of CAR T-cell therapy in Turkey?","a":"<p>CAR T-cell therapy success rates in Turkey range from 58% to 83% for most blood cancers. Specialized university hospitals report efficacy reaching 80% to 90% for pediatric Acute Lymphoblastic Leukemia. Academic trials like ISIKOK-19 for CD19+ tumors demonstrate an overall response rate of 72%.</p> <ul> <li><strong>Leukemia outcomes:</strong> Pediatric patients show up to 80% efficacy in leading Turkish university centers.</li> <li><strong>Lymphoma response:</strong> Patients achieve a 55% overall response rate with 25% reaching complete remission.</li> <li><strong>Clinical trial results:</strong> The ISIKOK-19 trial reported complete responses in 66% of leukemia participants.</li> <li><strong>Inpatient monitoring:</strong> Success requires 28 days of specialized hospitalization to manage potential side effects.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While success rates are high, the $100,000 price difference between packages at Istanbul Florence Nightingale and Medical Park Bahcelievler often reflects inclusive diagnostics. Lower-priced tiers usually cover the infusion and monitoring, whereas premium packages bundle extensive pre-treatment PET/CT scans and multidisciplinary consultations.</p> <p><strong>Patient Consensus:</strong> Individuals value the direct access to professors trained at institutions like Harvard or Cincinnati. However, some find the standard 28-day isolation period during cell recovery to be emotionally taxing despite the high clinical success.</p>"},{"q":"How are side effects managed?","a":"<p>Managing side effects for CAR T-cell therapy in Turkey involves intensive 28-day hospitalization for continuous monitoring by JCI-accredited hematology teams. Specialists use standardized protocols like tocilizumab infusions for cytokine release syndrome and levetiracetam for neurotoxicity to ensure patient safety during the critical 4-week recovery period.</p> <ul> <li><strong>Cytokine management:</strong> Surgeons use tocilizumab or siltuximab to resolve grade 2 CRS within 48 hours.</li> <li><strong>Neurological monitoring:</strong> Teams provide 24/7 nursing and EEG monitoring to manage ICANS with specific steroids.</li> <li><strong>Infection prophylaxis:</strong> Patients receive acyclovir and antifungals pre-lymphodepletion to prevent complications during neutropenia.</li> <li><strong>Long-term support:</strong> B-cell aplasia is managed with intravenous immunoglobulin (IVIG) infusions every 3-4 weeks.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While US centers often transition to outpatient care, Turkish clinics like Medical Park Bahcelievler mandate a full 28-day hospital stay. This longer inpatient phase allows JCI-certified teams to catch fever spikes immediately, which is vital since cytokine release syndrome often requires intervention within minutes to maintain high success rates.</p> <p><strong>Patient Consensus:</strong> Patients emphasize the necessity of daily bloodwork and 24/7 nursing support. Many recommend confirming the clinic has immediate ICU access and a steady supply of tocilizumab before starting the 4-week stay.</p>"},{"q":"What is the recovery period post-CAR T-cell infusion?","a":"<p>Recovery after CAR T-cell infusion typically spans 3 to 12 months, beginning with a critical 28-day acute monitoring phase. Patients generally remain hospitalized for 10 to 28 days in JCI-accredited Turkish facilities to manage potential side effects like cytokine release syndrome or neurotoxicity.</p> <ul> <li><strong>Hospitalization period:</strong> Most Turkish protocols require a 28-day stay for immediate medical surveillance.</li> <li><strong>Acute phase:</strong> Days 0–28 focus on monitoring cytokine release syndrome and neurological symptoms.</li> <li><strong>Driving restrictions:</strong> Patients must avoid driving for 8 weeks due to delayed seizure risks.</li> <li><strong>Immune reconstitution:</strong> Full recovery of the immune system often takes 6 to 12 months.</li> <li><strong>Long-term follow-up:</strong> Annual monitoring continues for up to 15 years to track late complications.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While standard protocols suggest a 14-day stay, top-tier Turkish clinics like Istanbul Florence Nightingale or Medical Park Bahcelievler often bundle a full 28-day hospitalization. This longer stay, often supervised by specialists trained at the Mayo Clinic or Harvard, ensures that the most volatile recovery window is managed entirely by clinical experts rather than in a hotel.</p> <p><strong>Patient Consensus:</strong> The first 2 weeks are often the most challenging, characterized by severe flu-like symptoms and high fevers. Most patients report significant energy improvements by month 3, though strict infection precautions remain vital for nearly a year.</p>"},{"q":"What is typically included in a CAR T-cell treatment package?","a":"<p>A CAR T-cell treatment package in Turkey includes T-cell collection via apheresis, genetic engineering in GMP-compliant labs, lymphodepleting chemotherapy, and the cellular infusion. These bundles specifically feature an extended 28-day hospital stay for intensive monitoring of cytokine release syndrome within JCI-accredited hematology-oncology units.</p> <ul> <li><strong>Medical screening:</strong> Includes PET/CT scans, biopsies, ECG mapping, and consultations with multidisciplinary specialist teams.</li> <li><strong>Cell manufacturing:</strong> Covers laboratory genetic engineering and expansion of T-cells in specialized facilities.</li> <li><strong>Inpatient care:</strong> Provides 28 days of hospitalization with 24-hour nursing and acute side-effect management.</li> <li><strong>Logistics support:</strong> Encompasses VIP airport-to-clinic transfers and dedicated personal coordinators for international patients.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While US CAR T-cell therapy costs average _price_compare_US_average_, Turkish packages offer savings of _price_percent_discount_% with a significant clinical advantage. Turkish protocols at centers like Medical Park often include a full 28-day hospital stay, whereas international standards sometimes move to outpatient care after 7–14 days. This extended inpatient period ensures immediate professional intervention for late-onset neurotoxicity without the patient needing to arrange local near-hospital housing.</p> <p><strong>Patient Consensus:</strong> Patients emphasize the importance of choosing packages with all-inclusive diagnostic testing to avoid unexpected billing. Many highlight that having a companion stay during the month-long hospitalization is essential for emotional support during the recovery phase.</p>"}],"h2":[{"text":"Comment ça fonctionne","kind":"content"},{"text":"Quel est le Coût pour votre Thérapie CAR T en Turquie ?","kind":"content"},{"text":"Ne Manquez pas les Offres Exclusives de thérapie CAR T en Turquie en novembre 2026","kind":"content"},{"text":"Découvrez les Meilleures Cliniques pour Votre Thérapie CAR T en Turquie : 6 Options Vérifiées et Prix","kind":"content"},{"text":"Aperçu de thérapie CAR T en Turquie","kind":"content"},{"text":"Obtenez une Évaluation Médicale pour Votre Thérapie CAR T en Turquie : Consultez Maintenant 13 Médecins Expérimentés","kind":"content"},{"text":"Avis sur Bookimed : Découvrez l'Expérience des Patients","kind":"content"},{"text":"Partager ce contenu","kind":"content"},{"text":"Histoires vidéo des patients de Bookimed","kind":"content"},{"text":"FAQ de thérapie CAR T en Turquie","kind":"content"},{"text":"Obtenez une consultation gratuite","kind":"content"}]},"placeholders":{"price_from":"{{price_from}}","clinics_count":"{{clinics_count}}","cities_count":"{{cities_count}}","savings_pct":"{{savings_pct}}","data_date":"{{data_date}}"},"legal":{"restricted_markets":{"status":"missing","reason":"not_collected"}},"conflicts":[{"field":"medical.hospital_nights","chosen":"offers","offers":28,"parsed_details":{"min":10,"max":21}}]}